SMAD2 and neoplasm: In the present report, we found that TGF-β treatment activated lnc-UTGF transcription via SMAD2/3, and lnc-UTGF in turn enhanced the TGF-β signaling by increasing the stability of SMAD2/4-mRNAs, which consequently promoted tumor metastasis.